Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

This study has been completed.
Sponsor:
Collaborators:
Novum Pharmaceutical Research Services
International Dermatology Research
Information provided by:
NovaBay Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01367314
First received: June 3, 2011
Last updated: June 6, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)